ArthNow Logo
ArthNow
•4 min read•
✦Reported by Business Line

India’s roads are getting a 'high-tech' upgrade: A new system promises to finally fix our crumbling infrastructure.

India’s roads are getting a 'high-tech' upgrade: A new system promises to finally fix our crumbling infrastructure.
Source: Business Line

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓ARRB Systems India received CRRI validation for its iPAVe technology on November 20, 2026.
  • ✓Showcased at the Indian Road Congress, this vehicle combines three survey tools into one platform.
  • ✓Anand Kumar said, "The successful validation of iPAVe is a significant milestone for ARRB Systems as it highlights" new road assessment capabilities.

Story at a Glance

Category
Indian Markets
Reported By
Business Line
Reading Speed
4 Minute(s)
Market Focus
India Economy

Showcased at the Indian Road Congress 2026, iPAVe is the only integrated platform of its kind in India, combining Network Survey Vehicle, Traffic Speed Deflectometer and Ground Penetrating Radar technologies in a single vehicle

NEW DELHI, Nov. 20, 2026 /PRNewswire/ -- In a significant development for India's road infrastructure assessment ecosystem, ARRB Systems India, the Indian arm of Australia-headquartered ARRB Systems, has announced the successful validation of its intelligent Pavement Assessment Vehicle (iPAVe) by the Central Road Research Institute (CRRI). The validation marks an important step towards the commercial deployment of an integrated pavement assessment solution designed to bring multiple road survey capabilities together in a single vehicle.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Business Line

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.